Table 1.
Reactive centre loop sequences for human serpins*
Serpin | P15 | P14 | P13 | P12 | P11 | P10 | P9 | P8 | P7 | P6 | P5 | P4 | P3 | P2 | P1 | P1’ | P2’ | P3’ | P4’ | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Inhibitory | A1 | G | T | E | A | A | G | A | M | F | L | E | A | I | P | M | S | I | P | P |
A2 | G | T | E | A | T | G | A | P | H | L | E | E | K | A | W | S | K | Y | Q | |
A3 | G | T | E | A | S | A | A | T | A | V | K | I | T | L | L | S | A | L | V | |
A4 | G | T | E | A | A | A | A | T | T | F | A | I | K | F | F | S | A | Q | T | |
A5 | G | T | R | A | A | A | A | T | G | T | I | F | T | F | R | S | A | R | L | |
A9 | G | T | E | A | T | A | A | T | T | T | K | F | I | V | R | S | K | D | G | |
A10 | G | T | E | A | V | A | G | I | L | S | E | I | T | A | Y | S | M | P | P | |
B1 | G | T | E | A | A | A | A | T | A | G | I | A | T | F | C | M | L | M | P | |
B2 | G | T | E | A | A | A | G | T | G | G | V | M | T | G | R | T | G | H | G | |
B3 | G | A | E | A | A | A | A | T | A | V | V | G | F | G | S | S | P | A | S | |
B4 | G | V | E | A | A | A | A | T | A | V | V | V | V | E | L | S | S | P | S | |
B6 | G | T | E | A | A | A | A | T | A | A | I | M | M | M | R | C | A | R | F | |
B7 | G | T | E | A | T | A | A | T | G | S | N | I | V | E | K | Q | L | P | Q | |
B8 | G | T | E | A | A | A | A | T | A | V | V | R | N | S | R | C | S | R | M | |
B9 | G | T | E | A | A | A | A | S | S | C | F | V | V | A | E | C | C | M | E | |
B10 | G | T | E | A | A | A | G | S | G | S | E | I | D | I | R | I | R | V | P | |
B11 | G | T | E | A | A | A | A | T | G | D | S | I | A | V | K | S | L | P | M | |
B12 | G | T | Q | A | A | A | A | T | G | A | V | V | S | E | R | S | L | R | S | |
B13 | G | T | E | A | A | A | A | T | G | I | G | F | T | V | T | S | A | P | G | |
C1 | G | S | E | A | A | A | S | T | A | V | V | I | A | G | R | S | L | N | P | |
D1 | G | T | Q | A | T | T | V | T | T | V | G | F | M | P | L | S | T | Q | V | |
E1 | G | T | V | A | S | S | S | T | A | V | I | V | S | A | R | M | A | P | E | |
E2 | G | T | K | A | S | A | A | T | T | A | I | L | I | A | R | S | S | P | P | |
F2 | G | V | E | A | A | A | A | T | S | I | A | M | S | R | M | S | L | S | ||
G1 | G | V | E | A | A | A | A | S | A | I | S | V | A | R | T | L | L | V | ||
I1 | G | S | E | A | A | A | V | S | G | M | I | A | I | S | R | M | A | V | L | |
I2 | G | S | E | A | A | T | S | T | G | I | H | I | P | V | I | M | S | L | A | |
Non‐inhibitory | A6 | G | V | D | T | A | G | S | T | G | V | T | L | N | L | T | S | K | P | I |
A7 | G | T | E | A | A | A | V | P | E | V | E | L | S | D | Q | P | E | N | T | |
A8 | G | R | E | P | T | E | S | T | Q | Q | L | N | K | P | E | V | L | E | V | |
B5 | G | G | D | S | I | E | V | P | G | A | R | I | L | Q | H | K | D | E | L | |
F1 | G | A | G | T | T | P | S | P | G | L | Q | P | A | H | L | T | F | P | L | |
H1 | G | N | P | F | D | Q | D | I | Y | G | R | E | E | L | R | S | P | K | L | |
H2 | G | N | P | F | D | Q | D | I | Y | G | R | E | E | L | R | S | P | K | L |
*Based on Chou–Fasman helix and sheet propensities, the RCL residues were dichotomized to give the top 10 β‐sheet prone amino acids (A, F, H, I, L, M, T, V, W and Y) and shaded in the table. A gap has been introduced at P6 for F2 and G1 to maintain the alignment of residues.